Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Silverstone Capital’s flagship L/S equity fund gained 4.92% in May, 5.31% YTD

Friday, June 11, 2010
Opalesque Industry Update - Silverstone Capital, a leading London-based equity long/short hedge fund manager that specializes in investments in the global automotive industry and related fields, today announced solid monthly performance numbers for May 2010 in what has been a highly challenging month for equity markets around the world. The flagship Silverstone Fund delivered a gross return of +4.92% for the month taking YTD gross performance to +5.31%, whilst the Monza Fund posted a gross return of +6.77% in May. Monza has year-to-date delivered a positive gross return of +10.65%.

Silverstone was founded in May 2004, and today manages investments in equity and equity linked products. The firm currently manages the Silverstone Fund and the Monza Fund. The flagship Silverstone Fund opened to outside investors in July 2004. Silverstone has throughout Q2 of 2010 continued to see strong international investor demand for its funds products, and the strong May numbers further reaffirms the unique advantages of the investment philosophy in the Silverstone Fund and the Monza Fund.

Saul Rubin, Founding Partner, Silverstone commented on May’s solid performance numbers: “ We are pleased with the May result but we continue to look forwards. Our intention continues to be to deliver good returns over the long run irrespective of the overall market conditions.” Corporate website: Source

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its